Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model.
about
When ubiquitin meets NF-κB: a trove for anti-cancer drug developmentVariable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugsA melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors.Tissue transglutaminase constitutively activates HIF-1α promoter and nuclear factor-κB via a non-canonical pathway.Epithelial Control of Gut-Associated Lymphoid Tissue Formation through p38α-Dependent Restraint of NF-κB Signaling.Enhancement of adoptive T cell transfer with single low dose pretreatment of doxorubicin or paclitaxel in mice.Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib.Neutrophil-Derived IL-1β Impairs the Efficacy of NF-κB Inhibitors against Lung Cancer.UVB-stimulated TNFα release from human melanocyte and melanoma cells is mediated by p38 MAPKPhase I trial of bortezomib and dacarbazine in melanoma and soft tissue sarcoma.Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.Targeting nuclear factor-kappa B to overcome resistance to chemotherapy.NF-κB in cancer: a matter of life and death.Cell fate regulated by nuclear factor-κB- and activator protein-1-dependent signalling in human melanocytes exposed to ultraviolet A and ultraviolet BEffects of consumption of whole grape powder on basal NF-κB signaling and inflammatory cytokine secretion in a mouse model of inflammation.The Direct and Indirect Roles of NF-κB in Cancer: Lessons from Oncogenic Fusion Proteins and Knock-in Mice.Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors
P2860
Q26827754-8B17A15C-DB3B-4240-A7BC-7D7C01BB77A0Q34123603-FF2280D5-A4E4-4802-BD18-FAD8C46843AEQ34132936-65872E26-37B2-426D-8924-0A76A82907A1Q34489967-EE30236A-3814-4B5F-91A3-7F7957E3BBF3Q35899739-26111DA4-A472-49D3-B426-49A2760EB416Q36688932-832637D3-9E76-4542-B1E1-BBFA917E9C34Q36882715-224B44F4-CAF0-44F6-B91E-9129DEF4998DQ37053032-AE9319EC-DD97-498E-AA77-2D92FA9E4D50Q37139268-A7C11ACE-7E95-47B5-8852-D345B321519BQ37351411-C07EDFA2-E51C-4A73-AD08-033D02532B11Q37694816-B2F22718-CA4D-429E-810B-BFFA3631B403Q40751673-D110D7C0-736B-4433-96C3-17AECD76219FQ42229340-D3D763B2-9F73-499C-8651-BAAFA98A9766Q42285401-FAB3218C-550C-4E2F-83B5-F3403D4352CFQ52724794-B9499EC3-F5F9-4963-A758-286320F36ABAQ55302804-B2FE5213-2B9D-4612-B1BF-450A038F7D8FQ57167736-E991D70D-435A-4019-8B4F-1AFDE0319071
P2860
Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cell-selective inhibition of N ...... a melanoma chemotherapy model.
@ast
Cell-selective inhibition of N ...... a melanoma chemotherapy model.
@en
type
label
Cell-selective inhibition of N ...... a melanoma chemotherapy model.
@ast
Cell-selective inhibition of N ...... a melanoma chemotherapy model.
@en
prefLabel
Cell-selective inhibition of N ...... a melanoma chemotherapy model.
@ast
Cell-selective inhibition of N ...... a melanoma chemotherapy model.
@en
P2093
P2860
P1433
P1476
Cell-selective inhibition of N ...... a melanoma chemotherapy model.
@en
P2093
Hensin Tsao
Howard B Cottam
Jin Mo Park
Min-Kyung Choo
Thomas Enzler
Yasuyo Sano
P2860
P304
P356
10.1158/2159-8290.CD-11-0143
P577
2011-11-01T00:00:00Z